ESG in action for Pharma

5 opportunities to go beyond environmental responsibility

Rethinking sustainability in Pharma

Sustainability in pharma is more than reducing emissions and waste—it’s about creating lasting value for people, the planet, and business. This whitepaper highlights five essential pillars to help pharma companies move beyond environmental responsibility: healthcare equity, ethical and transparent supply chains, corporate social responsibility, governance, and impactful innovation.

Discover practical strategies to navigate tightening regulations, integrate ESG into core business practices, and partner with sustainability-aligned suppliers. Learn how initiatives like Verilege™ and dsm-firmenich’s proprietary tools can help your organization measure impact, improve transparency, and deliver sustainable solutions.

Whether your goal is to build trust with stakeholders, enhance corporate resilience, or foster innovation that benefits patients and communities, this guide provides the insights needed to make meaningful, measurable progress.

1. EurEau. Urban waste water treatment directive. https://www.eureau.org/priorites/urban-waste-water-treatment-directive

2. European Commission. Packaging waste. https://environment.ec.europa.eu/topics/waste-and-recycling/packaging-waste_en

3. European Commission. Zero Pollution: Modernised rules on industrial and livestock rearing emissions come into effect. https:// environment.ec.europa.eu/news/revised-industrial-emissions-directive-comes-effect-2024-08-02_en

4. ESG and Global Investor Returns Study, 2023. https://www.kroll.com/en/reports/cost-of-capital/esg-global-investor-returns-study

Related content

Related articles

  • Ask-the-Expert: What does new clinical evidence mean for CBtru® and oral solid drug delivery?

    Ask-the-Expert: What does new clinical evidence mean for CBtru® and oral solid drug delivery?

    Explore what newly published CBtru® pharmacokinetic data means for solid oral drug development—and why clinical evidence underpins meaningful innovation.

  • From compliance to confidence: how pharmaceutical quality management is evolving

    From compliance to confidence: how pharmaceutical quality management is evolving

    Discover how pharmaceutical quality management is advancing through proactive strategies that reduce risk, improve visibility, and support compliance.

  • The vitamin C carbon problem, and how a pharma partnership solved it

    The vitamin C carbon problem, and how a pharma partnership solved it

    Discover how dsm-firmenich and Bayer reduced vitamin C’s carbon footprint by 49% through renewable energy, process innovation, and sustainable pharma collaboration.

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.